Professional Seasonal Analysis for Trading

Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)

Seasonality Analysis

Stocks 8 Years Analyzed

Cardiol Therapeutics Inc. - Class A Common Shares Annual Seasonality Statistics

14.95%
Avg Annual Return
48.8%
Avg Monthly Win Rate
6/12
Positive Months
8
Years Analyzed

Cardiol Therapeutics Inc. - Class A Common Shares Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January BEST 10.67%
63%
Strong
February 9.28%
50%
Weak
March -5.75%
25%
Very Weak
April 6.64%
63%
Strong
May -0.89%
43%
Weak
June 2.38%
57%
Moderate
July 6.92%
71%
Very Strong
August 4.46%
43%
Weak
September -4.12%
43%
Weak
October WORST -7.61%
43%
Weak
November -6.01%
29%
Very Weak
December -1.03%
57%
Weak

Cardiol Therapeutics Inc. - Class A Common Shares 2026 vs Historical Pattern

Current Position
98.97
Historical Avg Position
40.8
Deviation
+58.17
Performance
Significantly Above Average

Cardiol Therapeutics Inc. - Class A Common Shares Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for CRDL with overlay patterns, custom date ranges, and more.

Create Free Account

Cardiol Therapeutics Inc. - Class A Common Shares Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Cardiol Therapeutics Inc. - Class A Common Shares Seasonal Historical Performance

Historical Performance

See historical average returns for CRDL across multiple timeframes.

Create Free Account

About Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) Seasonality

Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) has been analyzed using 8 years of historical data to identify seasonal patterns. Classified under Stocks, Cardiol Therapeutics Inc. - Class A Common Shares shows distinct seasonal tendencies based on historical data.

The strongest month for Cardiol Therapeutics Inc. - Class A Common Shares is historically January, with an average return of 10.67% and a win rate of 63%. Conversely, October tends to be the weakest month, averaging -7.61% return.

Looking at the full calendar year, Cardiol Therapeutics Inc. - Class A Common Shares has an average annual return of 14.95% with an overall monthly win rate of 48.8%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Cardiol Therapeutics Inc. - Class A Common Shares has a consistency score of 57.5 (Fair), based on 8 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Cardiol Therapeutics Inc. - Class A Common Shares Seasonality FAQ

What is the best month to buy Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)?

Historically, January has been the best month for Cardiol Therapeutics Inc. - Class A Common Shares, with an average return of 10.67% and a win rate of 63%. However, past performance does not guarantee future results.

What is the worst month for Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)?

Based on historical data, October has been the weakest month for Cardiol Therapeutics Inc. - Class A Common Shares, with an average return of -7.61%. This is a historical observation and does not guarantee future results.

How reliable is CRDL seasonality data?

The seasonality analysis for Cardiol Therapeutics Inc. - Class A Common Shares is based on 8 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Cardiol Therapeutics Inc. - Class A Common Shares seasonality in my trading?

Use Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.